The US valganciclovir market is experiencing steady growth due to the increasing number of organ transplant procedures, rising prevalence of immunocompromised patients, and growing demand for effective antiviral therapies. Advanced healthcare infrastructure, strong transplant care programs, and continuous investments in infectious disease management are further supporting market expansion...